Just an update decided to do NCT 03338790 with Nivolumab and Rucaparib, study closer to me, less travel and parp inhibitor may help . Anyone on either of this trials NCT 03338790 (An Investigational Immunotherapy Study of Nivolumab in Combination With Rucaparib, Docetaxel, or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (CheckMate 9KD))
or NCT02897375 (Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors)
Thanks